Patent Ductus Arteriosus (PDA)

Patent Ductus Arteriosus (PDA) is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Ductus Arteriosus, Patent · Patent Ductus Arteriosus · PDA · Persistent Ductus Arteriosus · Ductus Arteriosus Patent
Classified under: Cardiovascular Diseases
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Pregnancy, Puerperium, and Perinatal Conditions
Indicated drugs: Alprostadil
Ibuprofen
Indomethacin

Resolves to

Vocabularies

MeSHM0006877ICD-10Q25.0SNOMED CT156928009MedDRA10013807UMLSC0013274

What you can answer from here — as of October 23, 2026

3Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

81Clinical trialsPhase, status and sponsor resolved per trial

3Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Patent Ductus Arteriosus (PDA) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.